Prognostic implications of arrhythmias during primary percutaneous coronary interventions for ST-elevation myocardial infraction

References

• Lopez AD, Murray CC. Global burden of disease, 1990-2020. Nat Med 1998;4:241-3
   Web of Science ®Google Scholar
• Grines CL, Browne KF, Macro J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;38:673-9
   Google Scholar
• Gruentzig AR. Transluminal dilatation of coronary artery stenosis. Lancet 1978;1:263
   PubMed Web of Science ®Google Scholar
• Mehta RH, Harjai KJ, Grines L, et al. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am CollCardiol 2004;43(10):1765-72
   Web of Science ®Google Scholar
• Hajj-Ali R, Ezzeddine R, Jadonath R, et al. Use of low-osmolar ionic contrast agents increases the risk of sustained ventricular arrhythmias during diagnostic coronary angiography. Am J Cardiol 2001;88(5A Suppl):TCT298
   Web of Science ®Google Scholar
• Tennant R, Wiggers CJ. The effect of coronary occlusion on myocardial contraction. Am J Physiol 1935;112:351-61
   Google Scholar
• Coronel R, Wilms-Schopman FJ, Janse MJ. Profibrillatory effects of intracoronary thrombus in acute regional ischemia of the in situ porcine heart. Circulation 1997;96:3985-91
   PubMed Web of Science ®Google Scholar
• Matsuma K, Jeremy RW, Schaper J, et al. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 1988;97:795-804
   Google Scholar
• Ilia R, Zahger D, Carlos Cafri C, et al. Predicting survival with reperfusion arrhythmias during primary percutaneous coronary intervention for acute myocardial infarction. IMAJ 2007;9:21-3
   Google Scholar
• Bredlau CE, Roubin GS, Leimgruber PP, et al. In-hospital mortality in patients undergoing elective coronary angioplasty. Circulation 1985;72:1044-52
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Stebbins AL, Callif RM, et al. Sustained ventricular tachycardia and mortality among patients with acute myocardial infarction: results from GUSTO III trial. Am Heart J 2003;145:515-21
   PubMed Web of Science ®Google Scholar
• Wong CK, White HD, Wilcox RG, et al. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries. Heart 2002;88(4):357-62
   PubMed Web of Science ®Google Scholar
• Nilsson KRJr, Al-Khatib SM, Zhou Y, et al. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart 2010;96:838-42
   PubMed Web of Science ®Google Scholar
• Mehta RH, Starr AZ, Lopes RD, et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA 2009;301(17):1779-89
   PubMed Web of Science ®Google Scholar
• Mehta RH, Starr AZ, Lopes RD, et al. Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk. Am Heart J 2011;161(4):782-9
   PubMed Web of Science ®Google Scholar
• Mehta RH, Yu J, Piccini JP, et al. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). Am J Cardiol 2012;109(6):805-12
   PubMed Web of Science ®Google Scholar
• Terkelsen CJ, Sørensen JT, Kaltoft AK, et al. Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 2009;104(12):1641-6
   PubMed Web of Science ®Google Scholar
• Piccini JP, Berger JS, Brown DL. Early sustained ventricular arrhythmias complicating acute myocardial infarction. Am J Med 2008;121(9):797-804
   PubMed Web of Science ®Google Scholar
• Timmer JR, Breet N, Svilaas T, et al. Predictors of ventricular tachyarrhythmia in high-risk myocardial infarction patients treated with primary coronary intervention. Neth Heart J 2010;18(3):122-8
   PubMed Web of Science ®Google Scholar
• Ibanez B, Macaya C, Sánchez-Brunete V, et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in CardioprotectionDuring an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation 2013;128(14):1495-503
   PubMed Web of Science ®Google Scholar
• Valle JA, Zhang M, Dixon S, et al. Impact of pre-procedural beta blockade on inpatient mortality in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol 2013;111(12):1714-20
   PubMed Web of Science ®Google Scholar
• Zipes DP, Camm AJ, Borggrefe M, et al. American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association and the Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006;27(17):2099-140
   PubMed Web of Science ®Google Scholar
• Gorenek B, BlomströmLundqvist C, BrugadaTerradellas J, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace 2014;16:1655-73
   PubMed Web of Science ®Google Scholar
• Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351(24):2481-8
   PubMed Web of Science ®Google Scholar
• Steinbeck G, Andresen D, Seidl K, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009;361(15):1427-36
   PubMed Web of Science ®Google Scholar
• Epstein AE, Abraham WT, Bianco NR, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am CollCardiol 2013;62(21):2000-7
   Web of Science ®Google Scholar
• Lopes RD, Elliott LE, White HD, et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J 2009;30(16):2019-28
   PubMed Web of Science ®Google Scholar
• Rene AG, Généreux P, Ezekowitz M, et al. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial. Am J Cardiol 2014;113(2):236-42
   PubMed Web of Science ®Google Scholar
• Beukema RJ, Elvan A, Ottervanger JP, et al. Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance. Neth Heart J 2012;20(4):155-60
   PubMed Web of Science ®Google Scholar
• Kinjo K, Sato H, Sato H, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2003;92(10):1150-4
   PubMed Web of Science ®Google Scholar
• Lip GYH, Windecker S, Huber K, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology.Working Group on Thrombosis, European Heart Rhythm Association [EHRA], European Association of Percutaneous Cardiovascular Interventions [EAPCI] and European Association of Acute Cardiac Care [ACCA]. Eur Heart J 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. 2014;AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am CollCardiol 2014; pii: S0735-1097(14)01740-9. [Epub ahead of print]
   Google Scholar
• Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation – developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14(10):1385-413
   PubMed Web of Science ®Google Scholar
• Guerrero M, Harjai K, Stone GW, et al. Comparison of the prognostic effect of left versus right versus no bundle branch block on presenting electrocardiogram in acute myocardial infarction patients treated with primary angioplasty in the Primary Angioplasty in Myocardial Infarction Trials. Am J Cardiol 2005;96:482-8
   PubMed Web of Science ®Google Scholar
• Vivas D, Pérez-Vizcayno MJ, Hernández-Antolín R, et al. Prognostic implications of bundle branch block in patients undergoing primary coronary angioplasty in the stent era. Am J Cardiol 2010;105:1276-83
   PubMed Web of Science ®Google Scholar
• Gang UJO, Hvelplund A, Pedersen S, et al. High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. Europace 2012;14:1639-45
   PubMed Web of Science ®Google Scholar
• Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34(29):2281-329
   PubMed Web of Science ®Google Scholar